99 related articles for article (PubMed ID: 19357443)
21. Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender.
Cavalca V; Veglia F; Squellerio I; Marenzi G; Minardi F; De Metrio M; Cighetti G; Boccotti L; Ravagnani P; Tremoli E
Eur J Clin Invest; 2009 Apr; 39(4):267-72. PubMed ID: 19292881
[TBL] [Abstract][Full Text] [Related]
22. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
23. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
[TBL] [Abstract][Full Text] [Related]
24. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C infection in hemodialysis patients: Protective against oxidative stress?
Sezer S; Tutal E; Aldemir D; Türkoglu S; Demirel OU; Afsar B; Ozdemir FN; Haberal M
Transplant Proc; 2006 Mar; 38(2):406-10. PubMed ID: 16549132
[TBL] [Abstract][Full Text] [Related]
26. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
[TBL] [Abstract][Full Text] [Related]
27. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
Bradran A; Nasri H
J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant level in normal and dialyzed patients using FRAP method.
Mustafa G; Khan IU; Khan MK; Sualeh M
Pak J Pharm Sci; 2010 Apr; 23(2):175-7. PubMed ID: 20363695
[TBL] [Abstract][Full Text] [Related]
29. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
31. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
[TBL] [Abstract][Full Text] [Related]
32. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress markers in pre-uremic patients.
Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
Lee DH; Zacharski LR; Jacobs DR
Am Heart J; 2006 Jun; 151(6):1247.e1-7. PubMed ID: 16781229
[TBL] [Abstract][Full Text] [Related]
36. [Effects of ultrapure water on the levels of oxidative stress and inflammation parameters in maintenance hemodialysis patients].
Zhang Y; Liu J; Tao HQ; Liu ZQ; Tian JW
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1435-7. PubMed ID: 17884796
[TBL] [Abstract][Full Text] [Related]
37. Plasma non-enzymatic antioxidants-vitamin C, E, beta-carotenes, reduced glutathione levels and total antioxidant activity in oral sub mucous fibrosis.
Bose KS; Vyas P; Singh M
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):530-2. PubMed ID: 22696882
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of oxidative and nitrosative stress in hemodialysis patients.
Namiduru ES; Tarakcioglu M; Tiryaki O; Usalan C
Minerva Med; 2010 Oct; 101(5):305-10. PubMed ID: 21048552
[TBL] [Abstract][Full Text] [Related]
39. Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions.
Stepniewska J; Dolegowska B; Ciechanowski K; Kwiatkowska E; Millo B; Chlubek D
Arch Med Res; 2006 Apr; 37(3):353-9. PubMed ID: 16513484
[TBL] [Abstract][Full Text] [Related]
40. Pathological role of aminolevulinate in uremic patients.
Hasuike Y; Nonoguchi H; Tokuyama M; Hata R; Kitamura R; Hori K; Nanami M; Otaki Y; Kuragano T; Nakanishi T
Ther Apher Dial; 2011 Feb; 15(1):28-33. PubMed ID: 21272249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
